Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gill

Showing results (21-30 of 443) with videos related to

Pageof 45
Sort By:
Seminars in Nephrology|September 16, 2009
Is living kidney donation the answer to the economic problem of end-stage renal disease?Scott Klarenbach, Lianne Barnieh, John Gill
International Journal of STD & AIDS|June 24, 2018
Long-term HIV/AIDS survivors: Patients living with HIV infection retained in care for over 20 years. What have we learned?Hartmut B Krentz, M John Gill
AIDS Patient Care and Stds|July 17, 2008
Participation in HIV research: the importance of clinic contact factorsCatherine A Worthington, M John Gill
AIDS (London, England)|February 25, 2003
The impact on health-related quality of life of treatment interruptions in HIV-1-infected patientsHartmut B Krentz, M John Gill
AIDS Patient Care and Stds|November 7, 2015
The Impact of Non-Antiretroviral Polypharmacy on the Continuity of Antiretroviral Therapy (ART) Among HIV PatientsHartmut B Krentz, M John Gill
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 27, 2015
Functional status metrics in kidney transplantation: implications for patients, programs, and policy makersKrista L Lentine, John Gill, David Axelrod
Lancet (London, England)|November 10, 2019
Protecting the health of children moving to CanadaTaj Jadavji, Raynell Lang, M John Gill
Expert Review of Anti-Infective Therapy|April 21, 2011
Impact of current antiretroviral therapies on neuroAIDSPornpun Vivithanaporn, M John Gill, Christopher Power
Neurologic Clinics|July 29, 2008
HIV infection of the central nervous system: clinical features and neuropathogenesisLysa Boissé, M John Gill, Christopher Power
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 11, 2007
The oncology impact of highly active antiretroviral therapyRichard Schlichemeyer, Carole Chambers, M John Gill
Pageof 45

Showing results (21-30 of 443) with videos related to

Sort By:
Pageof 45
Seminars in Nephrology|September 16, 2009
Is living kidney donation the answer to the economic problem of end-stage renal disease?Scott Klarenbach, Lianne Barnieh, John Gill
International Journal of STD & AIDS|June 24, 2018
Long-term HIV/AIDS survivors: Patients living with HIV infection retained in care for over 20 years. What have we learned?Hartmut B Krentz, M John Gill
AIDS Patient Care and Stds|July 17, 2008
Participation in HIV research: the importance of clinic contact factorsCatherine A Worthington, M John Gill
AIDS (London, England)|February 25, 2003
The impact on health-related quality of life of treatment interruptions in HIV-1-infected patientsHartmut B Krentz, M John Gill
AIDS Patient Care and Stds|November 7, 2015
The Impact of Non-Antiretroviral Polypharmacy on the Continuity of Antiretroviral Therapy (ART) Among HIV PatientsHartmut B Krentz, M John Gill
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 27, 2015
Functional status metrics in kidney transplantation: implications for patients, programs, and policy makersKrista L Lentine, John Gill, David Axelrod
Lancet (London, England)|November 10, 2019
Protecting the health of children moving to CanadaTaj Jadavji, Raynell Lang, M John Gill
Expert Review of Anti-Infective Therapy|April 21, 2011
Impact of current antiretroviral therapies on neuroAIDSPornpun Vivithanaporn, M John Gill, Christopher Power
Neurologic Clinics|July 29, 2008
HIV infection of the central nervous system: clinical features and neuropathogenesisLysa Boissé, M John Gill, Christopher Power
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 11, 2007
The oncology impact of highly active antiretroviral therapyRichard Schlichemeyer, Carole Chambers, M John Gill
Pageof 45